IL200449A0 - Triol form of rosuvastatin - Google Patents
Triol form of rosuvastatinInfo
- Publication number
- IL200449A0 IL200449A0 IL200449A IL20044909A IL200449A0 IL 200449 A0 IL200449 A0 IL 200449A0 IL 200449 A IL200449 A IL 200449A IL 20044909 A IL20044909 A IL 20044909A IL 200449 A0 IL200449 A0 IL 200449A0
- Authority
- IL
- Israel
- Prior art keywords
- rosuvastatin
- triol form
- triol
- Prior art date
Links
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title 1
- 229960000672 rosuvastatin Drugs 0.000 title 1
- 150000004072 triols Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90691407P | 2007-03-13 | 2007-03-13 | |
| US91846607P | 2007-03-15 | 2007-03-15 | |
| PCT/US2008/003470 WO2008112317A2 (en) | 2007-03-13 | 2008-03-13 | Triol form of rosuvastatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL200449A0 true IL200449A0 (en) | 2010-04-29 |
Family
ID=39650560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL200449A IL200449A0 (en) | 2007-03-13 | 2009-08-18 | Triol form of rosuvastatin |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2121631A2 (pt) |
| JP (1) | JP5330225B2 (pt) |
| KR (1) | KR100945760B1 (pt) |
| BR (1) | BRPI0803085A2 (pt) |
| CA (1) | CA2680604C (pt) |
| IL (1) | IL200449A0 (pt) |
| MX (1) | MX2008014552A (pt) |
| WO (1) | WO2008112317A2 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011154015A1 (en) * | 2010-06-07 | 2011-12-15 | Pharmathen S.A. | Improved process for the preparation of propenal intermediate and derivatives thereof |
| CN112782333B (zh) * | 2020-12-25 | 2022-07-12 | 石家庄四药有限公司 | 一种匹伐他汀异丙基叔丁酯非对映异构体的hplc检测方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005056534A1 (en) * | 2003-12-02 | 2005-06-23 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
-
2008
- 2008-03-13 BR BRPI0803085-5A patent/BRPI0803085A2/pt not_active IP Right Cessation
- 2008-03-13 EP EP08726880A patent/EP2121631A2/en not_active Withdrawn
- 2008-03-13 MX MX2008014552A patent/MX2008014552A/es active IP Right Grant
- 2008-03-13 JP JP2009504512A patent/JP5330225B2/ja not_active Expired - Fee Related
- 2008-03-13 KR KR1020087027688A patent/KR100945760B1/ko not_active Expired - Fee Related
- 2008-03-13 WO PCT/US2008/003470 patent/WO2008112317A2/en not_active Ceased
- 2008-03-13 CA CA2680604A patent/CA2680604C/en not_active Expired - Fee Related
-
2009
- 2009-08-18 IL IL200449A patent/IL200449A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5330225B2 (ja) | 2013-10-30 |
| KR20090010195A (ko) | 2009-01-29 |
| CA2680604C (en) | 2012-08-07 |
| MX2008014552A (es) | 2009-03-09 |
| WO2008112317A2 (en) | 2008-09-18 |
| CA2680604A1 (en) | 2008-09-18 |
| KR100945760B1 (ko) | 2010-03-08 |
| JP2009519353A (ja) | 2009-05-14 |
| WO2008112317A3 (en) | 2008-11-06 |
| BRPI0803085A2 (pt) | 2011-08-30 |
| EP2121631A2 (en) | 2009-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2185570A4 (en) | NOVEL GLUCCOKINASE ACTIVATORS | |
| EP2191397A4 (en) | ENHANCED REJECTION OF NON-VOCABULARY WORDS | |
| IL219133A0 (en) | Antimicrobial compounds and methods of making and using the same | |
| IL216973A0 (en) | Heterocyclic compounds and their uses | |
| ZA200903533B (en) | Process for the preparation of rosuvastatin | |
| IL219135A0 (en) | Antimicrobial compounds and methods of making and using the same | |
| IL214746A0 (en) | Substituted pyrimidines for the treatment of cancer | |
| IL257837A (en) | Antimicrobial compounds and methods for their preparation and use | |
| ZA201106585B (en) | Pyrimidine compound | |
| AP2008004406A0 (en) | Methods of managing timberland | |
| ZA201102604B (en) | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes | |
| IL215039A0 (en) | Use of rosuvastatin lactols as medicaments | |
| PL2387566T3 (pl) | Sposób przygotowania rosuwastatyny | |
| PL2133419T3 (pl) | Zastosowania beta-dipeptydów cyjanoficyny | |
| PL2328545T3 (pl) | Zastosowanie glukozyloglicerolu | |
| SG10201406631TA (en) | Antimicrobial compounds and methods of making and using the same | |
| EP2328873A4 (en) | PREPARATION OF RANOLAZINE | |
| AP2784A (en) | Methods of managing timberland | |
| PL2233133T3 (pl) | Trwałe kompozycje rozuwastatyny | |
| PL2237782T3 (pl) | Zastosowanie tetrahydropirymidyn | |
| IL200449A0 (en) | Triol form of rosuvastatin | |
| GB201114396D0 (en) | Location of basesation | |
| GB0703514D0 (en) | Use of riboflavin | |
| PL384673A1 (pl) | Zestaw podokładzinowych listew dekoracyjnych | |
| PL381510A1 (pl) | Sposób otrzymywania nowych pirymidynowych azanukleozydów |